ES2085924T3 - Compuestos quelatantes y su utilizacion. - Google Patents

Compuestos quelatantes y su utilizacion.

Info

Publication number
ES2085924T3
ES2085924T3 ES91105704T ES91105704T ES2085924T3 ES 2085924 T3 ES2085924 T3 ES 2085924T3 ES 91105704 T ES91105704 T ES 91105704T ES 91105704 T ES91105704 T ES 91105704T ES 2085924 T3 ES2085924 T3 ES 2085924T3
Authority
ES
Spain
Prior art keywords
sub
cooh
chelate
chelating compound
chelating compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91105704T
Other languages
English (en)
Inventor
Shigemi Seri
Hirohiko Yamauchi
Makoto Azuma
Yoji Arata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14107923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2085924(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Application granted granted Critical
Publication of ES2085924T3 publication Critical patent/ES2085924T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/41—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A61K51/048—DTPA (diethylenetriamine tetraacetic acid)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN COMPUESTO QUELANTE QUE TIENE LA FORMULA: (R-NHOC-CH SUB 2) SUB N-A-(CH SUB 2 COOH) SUB M (I) EN DONDE R ES UN GRUPO ORGANICO AROMATICO QUE CONTIENE UN ANILLO, A ES UN RESIDUO DE UN ACIDO AMINOPOLIACETICO EXCLUIDOS LOS GRUPOS DE ACIDO ACETICO (-CH SUB 2 COOH) DEL MISMO, M ES UN NUMERO ENTERO DE DOS COMO MINIMO Y N ES UN ENTERO DE 1 O 2, O SU SAL, QUE TIENE UNA ESPECIFICIDAD A UN SISTEMA HEPATOBILIAR DE MODO QUE UN COMPUESTO DE QUELATO FORMADO ENTRE DICHO COMPUESTO QUELANTE Y UN ELEMENTO METALICO A TRAVES DE UN ENLACE DE QUELATO ES UTIL COMO AGENTES DE DIAGNOSTICO O TERAPEUTICO PARA LOS ORGANOS Y TEJIDOS HEPATOBILIARES.
ES91105704T 1990-04-10 1991-04-10 Compuestos quelatantes y su utilizacion. Expired - Lifetime ES2085924T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2094353A JP2776953B2 (ja) 1990-04-10 1990-04-10 多官能性金属キレート化合物とその用途

Publications (1)

Publication Number Publication Date
ES2085924T3 true ES2085924T3 (es) 1996-06-16

Family

ID=14107923

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91105704T Expired - Lifetime ES2085924T3 (es) 1990-04-10 1991-04-10 Compuestos quelatantes y su utilizacion.

Country Status (10)

Country Link
US (2) US5196576A (es)
EP (1) EP0451824B1 (es)
JP (1) JP2776953B2 (es)
KR (1) KR100189388B1 (es)
AT (1) ATE134190T1 (es)
AU (1) AU634645B2 (es)
CA (1) CA2040204C (es)
DE (1) DE69117084T2 (es)
DK (1) DK0451824T3 (es)
ES (1) ES2085924T3 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807852B2 (ja) * 1991-07-18 1998-10-08 株式会社ミドリ十字 新規キレート化剤、該キレート化剤と金属原子との錯化合物及びそれを含む診断剤
TW213864B (es) * 1991-08-01 1993-10-01 Squibb & Sons Inc
EP1138334A3 (en) * 1992-06-09 2002-04-03 Neorx Corporation Pretargeting methods and compounds
US6358490B2 (en) 1992-06-09 2002-03-19 Neorx Corporation Three-step pretargeting methods and compounds
US6022966A (en) * 1993-11-22 2000-02-08 Neorx Corporation Pretargeting methods and compounds
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
US5911969A (en) 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US5578287A (en) * 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
DE69314613T3 (de) * 1992-07-03 2002-07-04 Welfide Corp., Osaka Neues chelatisierungsmittel, komplexverbindungen, die aus diesem mittel und metallatomen aufgebaut sind, und diagnostische mittel, die diese verbindungen enthalten
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5550160A (en) * 1992-07-31 1996-08-27 Australian Nuclear Science & Technology Organization Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US6908903B1 (en) 1994-12-07 2005-06-21 Aletheon Pharmaceuticals, Inc. Cluster clearing agents
US6172045B1 (en) 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
US5955605A (en) * 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
EP1033471B1 (en) * 1999-03-02 2003-09-17 Rohm And Haas Company Improved recovery and transportation of heavy crude oils
DE10002939C1 (de) * 2000-01-13 2001-09-20 Schering Ag Paramagnetische DOTA-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für die Herstellung von pharmazeutischen Mitteln
IL145210A (en) * 2000-12-06 2011-12-29 Aposense Ltd Use of pmbc in the preparation of an agent for the selective binding of cells, a method for the detection of apoptosis and a pharmaceutical composition for the treatment of a disease characterized by the presence of apoptosis in cells, tissues or cellular structures
IL147812A0 (en) * 2001-03-16 2002-08-14 N S T Neurosurvival Technologi Method for targeting chemical compounds to cells and pharmaceutical compositions used therein
IL153183A (en) 2002-06-04 2010-05-17 Aposense Ltd Agents for imaging and diagnostic methods using them
JP4569875B2 (ja) * 2003-02-27 2010-10-27 国立大学法人九州大学 Ｍｒｉ用造影剤
CN101010107A (zh) * 2004-08-26 2007-08-01 马林克罗特公司 监测肾功能的发光金属络合物
JP5338676B2 (ja) 2007-11-12 2013-11-13 三洋電機株式会社 非水電解質二次電池負極材、非水電解質二次電池用負極及び非水電解質二次電池
EP3089245B1 (en) 2013-12-25 2019-01-30 Shin-Etsu Chemical Co., Ltd. Negative electrode active material for nonaqueous electrolyte secondary batteries and method for producing same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH607920A5 (es) * 1976-05-31 1978-12-15 Solco Basel Ag
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
US4418208A (en) * 1980-12-29 1983-11-29 E. R. Squibb & Sons, Inc. N-Substituted iminodiacetic acids
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
JPS5828718A (ja) * 1981-08-14 1983-02-19 Toyo Contact Lens Co Ltd ソフトコンタクトレンズ
US4454107A (en) * 1982-08-30 1984-06-12 Merck & Co., Inc. Tc99m-Phenida, radioscintigraphic agent for diagnosis of hepatoniliary disease
US4943523A (en) * 1984-01-30 1990-07-24 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
US4843062A (en) * 1987-12-23 1989-06-27 American Home Products Corporation N-acyl-N-napthoylglycines as aldose reductase inhibitors
JP2815615B2 (ja) * 1988-06-07 1998-10-27 日本メジフィジックス株式会社 ジエチレントリアミン五酢酸誘導体とその用途

Also Published As

Publication number Publication date
EP0451824B1 (en) 1996-02-14
US5196576A (en) 1993-03-23
DE69117084D1 (de) 1996-03-28
CA2040204A1 (en) 1991-10-11
KR910018346A (ko) 1991-11-30
US5138039A (en) 1992-08-11
ATE134190T1 (de) 1996-02-15
DK0451824T3 (da) 1996-03-11
EP0451824A3 (en) 1992-09-02
EP0451824A2 (en) 1991-10-16
AU634645B2 (en) 1993-02-25
DE69117084T2 (de) 1996-10-02
AU7428191A (en) 1991-10-17
JPH03291260A (ja) 1991-12-20
KR100189388B1 (ko) 1999-06-01
JP2776953B2 (ja) 1998-07-16
CA2040204C (en) 2002-07-02

Similar Documents

Publication Publication Date Title
ES2085924T3 (es) Compuestos quelatantes y su utilizacion.
SE8301395D0 (sv) Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
AR002241A1 (es) Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo.
ES8406423A1 (es) Procedimiento para la preparacion de derivados de amino acidos, de efecto edulcorante
MX9303158A (es) Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih.
ES8700250A1 (es) Procedimiento para preparar derivados de acido 4-hidroxifenil-1,3-dioxan-cis-5-ilalquenoico
ES8404184A1 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
ES8207156A1 (es) Procedimiento para la preparacion de nuevas pirimidinonas .
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
ES8700240A1 (es) Procedimiento para preparar nuevos derivados de benzazocino-na y de benzaconinona
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES8507132A1 (es) Proceso para producir un derivado de tetrahidronaftilcarboxilato de fenilo
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES8507533A1 (es) Procedimiento para preparar derivados (+)-cianidan-3-ol.
ES2196001T3 (es) Derivado de pirroloazepina.
ES2010736A6 (es) Procedimiento para preparar nuevos derivados del acido furanuronico.
ES8401962A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
ES8403093A1 (es) Un metodo para preparar compuestos 3,5-bis(trifluorometil)fenoxi.
ES8900107A1 (es) Un procedimiento para preparar derivados de alcanoles heteropoliciclicos
ES8207162A1 (es) Un procedimiento para la preparacion de 5-(dihidroxifenox)tetrazoles.
ES8204415A1 (es) Un procedimiento para la preparacion de derivados de carboximidamida.
ES8201129A1 (es) Procedimiento de preparacion de un octapeptido de efectos antagonicos de la angiotensina-ii
GB1110600A (en) Method of making phosphorus-containing diols
ES8504814A1 (es) Un procedimiento para preparar una b-lactama

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451824

Country of ref document: ES